000 | 01209 a2200313 4500 | ||
---|---|---|---|
005 | 20250514181913.0 | ||
264 | 0 | _c20040511 | |
008 | 200405s 0 0 eng d | ||
022 | _a1534-5823 | ||
024 | 7 |
_a10.1177/1534582303262095 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKelly, Thomas H | |
245 | 0 | 0 |
_aClinical neuropharmacology of drugs of abuse: a comparison of drug-discrimination and subject-report measures. _h[electronic resource] |
260 |
_bBehavioral and cognitive neuroscience reviews _cDec 2003 |
||
300 |
_a227-60 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review | ||
650 | 0 | 4 | _aCues |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeuropharmacology _xmethods |
650 | 0 | 4 |
_aResearch Design _xstandards |
650 | 0 | 4 |
_aSubstance Abuse Detection _xmethods |
650 | 0 | 4 |
_aSubstance-Related Disorders _xclassification |
700 | 1 | _aStoops, William W | |
700 | 1 | _aPerry, Andrea S | |
700 | 1 | _aPrendergast, Mark A | |
700 | 1 | _aRush, Craig R | |
773 | 0 |
_tBehavioral and cognitive neuroscience reviews _gvol. 2 _gno. 4 _gp. 227-60 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/1534582303262095 _zAvailable from publisher's website |
999 |
_c14726326 _d14726326 |